Remus Pharmaceuticals Ltd
Closed
NSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 200 | ₹245,800 |
| Retail (Max — 13 Lots) | 13 | 1,300 | ₹1,597,700 |
| S-HNI (Min — 14 Lots) | 14 | 1,400 | ₹1,720,600 |
| B-HNI (Min — 68 Lots) | 68 | 6,800 | ₹8,357,200 |
Remus Pharmaceuticals Ltd is proposing an IPO on NSE SME under the SME category.
Opens 17 May 2023, closes 19 May 2023. Listing: 27 May 2023. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Remus Pharmaceuticals Ltd IPO is subscribed 1.00 times by May 19, 2023. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Remus Pharmaceuticals Ltd IPO retail category is subscribed 1.00 times as of 19 May 2023. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 17 May 2023 and closes 19 May 2023. Min investment: ₹122,900 (1 lot = 100 shares). UPI mandate: 5:00 PM on 19 May 2023.
The Remus Pharmaceuticals Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 25 May 2023. Refunds: on 26 May 2023.
The Remus Pharmaceuticals Ltd IPO listing date is 27 May 2023, Saturday. Listed on: NSE SME. Issue price: ₹1,229. Estimated listing: ₹1,229. GMP: NIL.
The Remus Pharmaceuticals Ltd IPO closes on 19 May 2023, Friday. UPI mandate: 5:00 PM on 19 May 2023. Allotment: 25 May 2023. Listing: 27 May 2023.